Beyond the Breaking News

FDA approves a first-of-its-kind pill to cut cholesterol in high-risk patients

Business News

FDA approves a first-of-its-kind pill to cut cholesterol in high-risk patients
Marty MakaryU.S. NewsHealth

The Food and Drug Administration has approved a first-of-its-kind pill that can drastically reduce cholesterol.

Select breaking news story 2 of 4FILE - The logo for Merck appears above a trading post on the floor of the New York Stock Exchange, May 1, 2025.

has approved a first-of-its-kind pill that can drastically reduce cholesterol in a way that's previously only been available with expensive, injectable drugs.from Merck was OK'd on Thursday for patients with artery-clogging cholesterol that persists even after taking statins, the standard medications for cutting heart attack risk. Merck will market its pill under the brand name Lipfendra. It's the first noninjectable medication that works by blocking a liver protein called PCSK9.

That protein limits the body's ability to clear cholesterol from the blood, andtargeting it have been available from Amgen and other drugmakers for more than a decade. But patient access has been stymied for years by high prices, insurance restrictions and limited prescribing by doctors. Statins block some of the liver’s production of cholesterol and are the cornerstone of treatment.

But even at the highest doses, many people need additional help lowering their LDL, or bad, cholesterol enough to meet medical guidelines. Merck, which has headquarters in Rahway, New Jersey, won approval based on two studies in high-risk patients who added the company's pill to their standard treatment, including statins. In one study of 3,000 patients, those taking Lipfendra saw their levels of LDL cholesterol drop more than 55% after six months.

In a second study, patients averaged a reduction of 59% compared with patients who received a dummy pill. That benefit dropped only slightly over a year, and side effects — including dizziness and diarrhea — were similar between those taking the pill or a placebo, researchers found. One caveat: The pill must be taken on an empty stomach.

Heart disease is the nation’s leading cause of death, and high LDL cholesterol, which causes plaque to build up in arteries, is a top risk factor for heart attacks and strokes. While an LDL level of 100 is considered fine for healthy people, doctors recommend lowering it to at least 70 once people develop high cholesterol or heart disease — and even lower for those at very high risk.

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content. Copyright 2026 The Associated Press. All rights reserved.

This material may not be published, broadcast, rewritten or redistributed without permission. Rivers at dangerous levels across South Texas — stay alertHill Country flooding: roads closed, waters still risingYou literally cannot get in or out of Uvalde right nowWhat to do with your insurance after the stormReports of tornado touching down in northwest Bexar County near The RimDrivers forced to turn around as flooding moves through the areaSan Antonio just got a mini golf course that looks like a tiny SA

GooglePlease follow us on Google to support us
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

ksatnews /  🏆 442. in US

Marty Makary U.S. News Health Washington News

 

United States Latest News, United States Headlines

Similar News: You can also read news stories similar to this one that we have collected from other news sources.

FDA approves a first-of-its-kind pill to cut cholesterol in high-risk patientsFDA approves a first-of-its-kind pill to cut cholesterol in high-risk patientsThe Food and Drug Administration has approved a first-of-its-kind pill that can drastically reduce cholesterol.
Read more »

FDA approves a first-of-its-kind pill to cut cholesterol in high-risk patientsFDA approves a first-of-its-kind pill to cut cholesterol in high-risk patientsThe Food and Drug Administration has approved a first-of-its-kind pill that can drastically reduce cholesterol.
Read more »

FDA approves a first-of-its-kind pill to cut cholesterol in high-risk patientsFDA approves a first-of-its-kind pill to cut cholesterol in high-risk patientsFDA approved Lipfendra, a Merck pill that drastically reduces bad cholesterol levels.
Read more »

FDA approves a first-of-its-kind pill to cut cholesterol in high-risk patientsFDA approves a first-of-its-kind pill to cut cholesterol in high-risk patientsLipfendra from Merck is the first noninjectable option for blocking a liver protein that interferes with the body’s ability to clear cholesterol from the blood.
Read more »



Render Time: 2026-08-07 13:45:26